Dr. Hannestad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
34 Park Street
New Haven, CT 06519Phone+1 203-932-5711
Education & Training
- Yale-New Haven Medical CenterResidency, Psychiatry, 2005 - 2006
- Duke University HospitalResidency, Internal Medicine/Psychiatry, 2003 - 2004
- Duke University HospitalInternship, Transitional Year, 2002 - 2003
- OtherClass of 1996
Certifications & Licensure
- MD State Medical License 2024 - 2026
- CA State Medical License 2017 - 2023
- CT State Medical License 2005 - 2017
Publications & Presentations
PubMed
- 184 citationsSynthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the BrainNabeel Nabulsi, Joël Mercier, Daniel Holden, Stephane Carre, Soheila Najafzadeh
Journal of Nuclear Medicine. 2016-05-01 - 58 citationsTranscranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trialRalph E. Hoffman, Kun Wu, Brian Pittman, John D. Cahill, Keith A. Hawkins
Biological Psychiatry. 2013-05-15 - 16 citationsPadsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach.Pierandrea Muglia, Jonas Hannestad, Christian Brandt, Steven DeBruyn, Massimiliano Germani
Brain Communications. 2020-11-02
Press Mentions
- Tranquis Therapeutics Announces Initiation of Phase 1 Study of TQS-168December 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: